The Beauty Health Company $SKIN Shares Sold by 180 Wealth Advisors LLC

180 Wealth Advisors LLC decreased its position in The Beauty Health Company (NASDAQ:SKIN) by 21.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,990 shares of the company’s stock after selling 17,832 shares during the quarter. 180 Wealth Advisors LLC’s holdings in Beauty Health were worth $122,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Newman Dignan & Sheerar Inc. lifted its holdings in shares of Beauty Health by 28.1% in the second quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock valued at $174,000 after buying an additional 20,000 shares during the period. Simplicity Wealth LLC acquired a new stake in shares of Beauty Health in the second quarter valued at $49,000. AQR Capital Management LLC purchased a new stake in shares of Beauty Health during the first quarter valued at $40,000. Kapitalo Investimentos Ltda purchased a new stake in shares of Beauty Health during the second quarter valued at $60,000. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Beauty Health by 5.0% during the first quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock valued at $892,000 after purchasing an additional 31,880 shares during the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Stock Up 6.9%

Shares of Beauty Health stock opened at $1.39 on Monday. The stock has a 50-day moving average price of $1.94 and a 200 day moving average price of $1.72. The company has a market cap of $176.28 million, a P/E ratio of -4.96 and a beta of 1.21. The company has a current ratio of 5.15, a quick ratio of 4.15 and a debt-to-equity ratio of 4.91. The Beauty Health Company has a 1 year low of $0.78 and a 1 year high of $2.69.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, August 7th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. Beauty Health had a negative return on equity of 32.82% and a negative net margin of 6.13%.The company had revenue of $78.20 million for the quarter, compared to analyst estimates of $74.67 million. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts expect that The Beauty Health Company will post -0.25 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently commented on SKIN. Roth Capital began coverage on Beauty Health in a report on Friday, September 19th. They set a “buy” rating and a $3.50 target price for the company. Cowen reaffirmed a “hold” rating on shares of Beauty Health in a report on Monday, September 22nd. TD Cowen upped their target price on Beauty Health from $2.00 to $2.50 and gave the company a “hold” rating in a report on Monday, September 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beauty Health in a report on Wednesday, October 8th. Finally, Zacks Research raised Beauty Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $2.81.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.